初诊2型糖尿病患者血清晚期糖基化终末产物、可溶性糖
基化终末产物受体水平分析
陈晓;周晓春;吴卫明;金艺璇;钱玲玲
【期刊名称】《国际中医中药杂志》 【年(卷),期】2013(035)001
【摘要】目的 了解初诊2型糖尿病患者血清晚期糖基化终末产物(AGEs)、可溶性糖基化终末产物受体(sRAGE)水平,为预防初诊2型糖尿病并发症的发生、延缓其发展提供依据.方法 收集2010年9月至2011年12月江苏省常熟市中医院(新区医院)内分泌科初诊为2型糖尿病的患者56例,另筛选健康人群30例为对照组,检测各类临床及生化指标,采用酶联免疫吸附法检测血清AGEs、sRAGE水平.结果 初诊2型糖尿病患者血清AGEs水平(1379.2±431.8) pg/ml与对照组(1154.5±326.4) pg/ml比较差异有统计学意义(P＜0.05);血清sRAGE水平(14.6±9.3) ng/ml与对照组(19.5±8.9) ng/ml比较差异有统计学意义(P＜0.05).初诊2型糖尿病患者血清AGEs水平与糖化血红蛋白(HbA1c)水平正相关,血清sRAGE水平与低密度脂蛋白胆固醇(LDL-C)负相关.结论 初诊2型糖尿病患者血清AGEs水平高于正常人群、血清sRAGE水平低于正常人群.%Objective To understand the serum levels of advanced glycation end products (AGEs),soluble receptor for advanced glycation end products (sRAGE) in newly diagnosed patients with type 2 diabetes.Methods 60 patients of newly diagnosed type 2 diabetes were chosen from 2010 September to 2011 December in Department of Endocrinology Changshou Chinese medicine hospital in Jiangsu
Province,and 30 healthy people were screened as control group.Various clinical and biochemical parameters were detected,using enzyme-linked immunosorbent assay for the detection of serum AGEs and sRAGE levels.Results The levels of serum AGEs in newly diagnosed type 2 diabetic patients and control group were (1379.2 ± 431.8) and (1154.5 ±326.4) pg/ml,and there were significant differences between two groups (P＜0.05).The levels of serum sRAGE in newly diagnosed type 2 diabetic patients and control group were (14.6± 9.3)and (19.5 ± 8.9)ng/ml,and there were also significant differences between two groups (P＜0.05).The level of serum AGEs in newly diagnosed type 2 diabetic patients was positive correlation with glycosylated hemoglobin (HbA1c),and the level of serum sRAGE was associated with low density lipoprotein cholesterol (LDL-C) negative correlation.Conclusion The level of serum AGEs increase in newly diagnosed type 2 diabetic patients,and the level of serum sRAGE decrease in newly diagnosed type 2 diabetic patients.
【总页数】3页(5-7)
【关键词】2型糖尿病;晚期糖基化终末产物;可溶性糖基化终末产物受体 【作者】陈晓;周晓春;吴卫明;金艺璇;钱玲玲
【作者单位】215500 江苏省常熟市中医院(新区医院)六病区 【正文语种】中文 【中图分类】
【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_international-journal-traditional-chinese-medicine_thesis/0201216066865.html 【相关文献】
1.黄芪对初诊2型糖尿病患者血清晚期糖基化终末产物、可溶性糖基化终末产物受体水平的影响 [J], 周晓春; 吴卫明; 陈晓; 金艺璇
2.慢性阻塞性肺疾病患者血浆晚期糖基化终末产物和可溶性糖基化终末产物受体浓度变化及其临床意义 [J], 雷超; 胡占升
3.血清β-淀粉样蛋白及可溶性糖基化终末产物受体与新诊断2型糖尿病患者认知功能损害的关系 [J], 周莉; 房辉; 徐刚; 张翠林; 李玉凯; 关如花; 杨莹; 张雅中; 田金莉
4.晚期糖基化终产物受体、可溶性晚期糖基化终产物受体与2型糖尿病心血管并发症的关系 [J], 李平静(综述); 李雷; 杨荣礼(审校)
5.2型糖尿病对急性ST段抬高型心肌梗死患者血清可溶性晚期糖基化终产物受体水平的影响 [J], 杨瑞玲; 李丽燕; 赵旭东; 李平静
以上内容为文献基本信息，获取文献全文请下载
初诊2型糖尿病患者血清晚期糖基化终末产物、可溶性糖基化终末产
